Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nanomedicine ; 11(7): 1643-56, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26115640

ABSTRACT

In this study, we report that surface functional groups of single walled carbon nanotubes (f-SWCNT) are critical for mediating survival and ex vivo expansion of hematopoietic stem and progenitor cells (HSPC) in human umbilical cord blood (UCB). In comparison to amide (-O-NH2) and polyethylene-glycol (-PEG) functionalized SWCNT, carboxylic acid (-COOH) variants gave optimal viability support which correlated with maximal reduction of lethal mitochondrial superoxides in HSPC. Cytokine array illustrated that f-SWCNT-COOH maintained higher proportion of HSPC associated cytokines and minimal level of differentiation promoting factors. Transplantation of f-SWCNT-COOH expanded grafts in sub-lethally irradiated immunodeficient mice resulted in higher engraftment of HSPC in bone marrow compared to control when they were co-transplanted with non-expanded cells from the same UCB. Expanded grafts mediated higher survival rate of mice compared to non-expanded grafts due to lower graft-versus-host-disease which is likely a consequence of proportion of immune cells in the grafts. FROM THE CLINICAL EDITOR: Umbilical cord blood (UCB) is a potential source of hematopoietic stem and progenitor (HSPC) cells. One major hurdle for its clinical use is the insufficient yield of cell number. The authors in this study elegantly demonstrated the importance of various functional groups on single-walled carbon nanotubes (f-SWCNT) in enhancing ex vivo expansion of HSPC in UCB. The findings may pave a way for having UCB as a source for HSPC for clinical use in the future.


Subject(s)
Graft vs Host Disease/therapy , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/drug effects , Nanotubes, Carbon/chemistry , Animals , Cell Differentiation/drug effects , Cytokines/metabolism , Fetal Blood/drug effects , Graft vs Host Disease/pathology , Humans , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Nanotubes, Carbon/adverse effects , Superoxides/metabolism , Transplantation, Heterologous
2.
Nanomedicine ; 9(8): 1304-16, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23732300

ABSTRACT

In this study, carboxylic acid functionalized single walled carbon nanotubes (f-SWCNT-COOH) was shown to support the viability and ex vivo expansion of freeze-thawed, non-enriched hematopoietic stem and progenitor cells (HSPC) in human umbilical cord blood-mononucleated cells (UCB-MNC). Our in vitro experiments showed that f-SWCNT-COOH increased the viability of the CD45(+) cells even without cytokine stimulation. It also reduced mitochondrial superoxides and caspase activity in CD45(+) cells. f-SWCNT-COOH drastically reduced the proportions of CD45(-) cells in the non-enriched UCB-MNC. Phenotypic expression analysis and functional colony forming units (CFU) showed significant ex vivo expansion of HSPC, particularly of CD45(+)CD34(+)CD38(-) population and granulocyte-macrophage (GM) colonies, in f-SWCNT-COOH augmented cultures supplemented with basal cytokines. In vivo data suggested that f-SWCNT-COOH expanded UCB-MNC could repopulate immunodeficient mice models with minimal acute or sub-acute symptoms of graft-versus-host disease (GVHD) and f-SWCNT-COOH dependent toxicity. FROM THE CLINICAL EDITOR: In this paper a novel method is presented by using single wall functionalized carbon nanotubes to enhance viability and ex vivo expansion of freeze-thawed, non-enriched hematopoietic stem and progenitor cells in human umbilical cord blood -mononucleated cells. Detailed data is presented about enhanced viability, including improved repopulation of immunodeficient mice models with minimal acute or sub-acute symptoms of graft-versus-host disease.


Subject(s)
Fetal Blood/cytology , Fetal Blood/transplantation , Hematopoietic Stem Cell Transplantation/methods , Hematopoietic Stem Cells/cytology , Nanotubes, Carbon/chemistry , ADP-ribosyl Cyclase 1/analysis , Animals , Antigens, CD34/analysis , Carboxylic Acids/chemistry , Cell Culture Techniques/methods , Cell Survival , Freezing , Graft vs Host Disease/prevention & control , Humans , Leukocyte Common Antigens/analysis , Mice , Mice, SCID
3.
Biol Blood Marrow Transplant ; 18(5): 674-82, 2012 May.
Article in English | MEDLINE | ID: mdl-22240732

ABSTRACT

Ex vivo expansion of cord blood (CB) hematopoietic stem cells and cotransplantation of 2 CB units (CBUs) could enhance the applicability of CB transplantation in adult patients. We report an immunodeficient mouse model for cotransplantation of ex vivo expanded and unexpanded human CB, showing enhanced CB engraftment and provide proof of concept for this transplantation strategy as a means of overcoming the limiting cell numbers in each CBU. CBUs were expanded in serum-free medium supplemented with stem cell factor, Flt-3 ligand, thrombopoietin, and insulin growth factor binding protein-2 together with mesenchymal stromal cell coculture. Unexpanded and expanded CB cells were cotransplanted by tail vein injection into 45 sublethally irradiated nonobese diabetic SCID-IL2γ(-/-) (NSG) mice. Submandibular bleeding was performed monthly, and mice were sacrificed 4 months after transplantation to analyze for human hematopoietic engraftment. Expansion of non-CD34(+) selected CB cells yielded 40-fold expansion of CD34(+) cells and 3.1-fold expansion of hematopoietic stem cells based on limiting dilution analysis of NSG engraftment. Mice receiving expanded grafts exhibited 4.30% human cell repopulation, compared with 0.92% in mice receiving only unexpanded grafts at equivalent starting cell doses, even though the unexpanded graft predominated in long-term hematopoiesis (P = .07). Ex vivo expanded grafts with lower initiating cell doses also showed equivalent engraftment to unexpanded grafts with higher cell dose (8.0% versus 7.9%; P = .93). In conclusion, ex vivo expansion resulted in enhanced CB engraftment despite eventual rejection by the unexpanded CBU.


Subject(s)
Fetal Blood/transplantation , Hematopoietic Stem Cell Transplantation/methods , Hematopoietic Stem Cells/drug effects , Insulin-Like Growth Factor Binding Protein 2/pharmacology , Mesenchymal Stem Cells/drug effects , Animals , Antigens, CD34/biosynthesis , Antigens, CD34/immunology , Cell Proliferation/drug effects , Cells, Cultured , Coculture Techniques , Fetal Blood/cytology , Fetal Blood/immunology , Graft Survival/immunology , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Humans , Injections, Intravenous , Membrane Proteins/pharmacology , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/immunology , Mice , Mice, SCID , Stem Cell Factor/pharmacology , Thrombopoietin/pharmacology , Transplantation, Heterologous , Whole-Body Irradiation
SELECTION OF CITATIONS
SEARCH DETAIL
...